SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902219-24-000043
Filing Date
2024-02-08
Accepted
2024-02-08 10:05:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 35722
  Complete submission text file 0000902219-24-000043.txt   37708
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Subject) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83043 | Film No.: 24607243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)